Login
Subscribe
Convalescent Plasma for COVID-19 Cuts Hospitalizations: Preprint
Convalescent Plasma for COVID-19 Cuts Hospitalizations: Preprint
Unlike studies of antibody-rich transfusions in hospitalized patients, which overall have not found clear benefits, a new randomized trial finds that early convalescent plasma treatment cuts hospitalizations in half.
Unlike studies of antibody-rich transfusions in hospitalized patients, which overall have not found clear benefits, a new randomized trial finds that early convalescent plasma treatment cuts hospitalizations in half.
plasma
Exercise-Associated Protein Boosts Brain Function in Mice
Chloe Tenn | Dec 9, 2021 | 5 min read
A study that transfused plasma from active to inactive mice suggests the protein clusterin enhances cognition.
WHO Rejects Convalescent Plasma Treatment for COVID-19
Chloe Tenn | Dec 6, 2021 | 2 min read
Current evidence suggests the treatment does not improve survival or reduce the need for ventilation in COVID-19 patients, the World Health Organization says.
NIH Halts Outpatient COVID-19 Convalescent Plasma Trial
Marcus A. Banks | Mar 4, 2021 | 4 min read
The decision adds to evidence that the benefits of plasma infusions from COVID-19 survivors may be limited, but advocates say the case isn’t closed.
Rapid Characterization of the SARS-CoV-2 Immune Response Using the Simple Western Multi-Antigen Serology Assay
The Scientist’s Creative Services Team | Oct 21, 2020 | 1 min read
The Simple Western automated western blotting platform accelerates characterization of the human IgG immune response to COVID-19.
SARS-CoV-2 Antibody Durability
The Scientist’s Creative Services Team | Oct 2, 2020 | 1 min read
Experts will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Alakananda Dasgupta | Sep 15, 2020 | 5 min read
A randomized controlled trial on the use of convalescent plasma therapy to treat coronavirus infections—the first in the world to be completed—yields disappointing results, but some doctors are not discouraged.